Nieuws

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.
By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its ...
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
Novo Nordisk is dinsdag met een verrassend bericht gekomen dat het dit jaar een magere omzet en winst verwacht. Het Deense bedrijf achter diabetes- en afslankmedicijnen Ozempic en Wegovy groeide ...
The 50-year-old is now on Novo Nordisk ’s Wegovy, but worries because it is less effective. Studies have shown Wegovy helps people lose less weight, on average, than Zepbound.
Shares in Novo Nordisk NOVO.B 0.16% plunged after it cut its guidance, a result from the company losing its lead in the booming market for weight-loss drugs, opening the door to competitors such ...
Obesitasmedicijn Wegovy verkrijgbaar bij apotheek Vanaf 1 juli is ook het afslankingsmiddel Wegovy op voorschrift verkrijgbaar bij Belgische apothekers. Wegovy is daarmee het 3e middel op basis ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs ...